Skip to content
Peptide research

Ovagen

Category
Bioregulators
Administration routes
InjectableOral
Regulatory status
Not FDA-approved

What it is

Ovagen is a synthetic tripeptide marketed for liver, kidney, and gut protection plus anti-aging effects via gene regulation. Evidence is speculative, resting on mechanistic and animal studies rather than controlled human trials, so benefits remain unproven in people. There is no human safety data and long-term effects are unknown. It is not an approved US drug, and available product is unregulated, purity uncertain.

Read Full record

Studied uses & evidence

Studied uses(4)

  • Anti-aging effects at the cellular level

    Low

    Single-lab rat kidney cell studies show reduced aging markers; no lifespan or human data.

  • Nephroprotective effects

    Low

    Multiple animal studies show kidney protection in injury models; no human trials yet.

  • GI mucosal protection

    Speculative

    No study of this peptide in gastrointestinal tissue; claim is purely theoretical.

Evidence limits

Evidence Level
Preclinical

All published research on EDL (Ovagen) is preclinical — in vitro cell culture and animal (rat) models. No registered clinical trials. The broader Khavinson program has extensive Russian clinical experience, but for other peptides (Thymalin, Cortexin), not Ovagen specifically.

Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)

Cautions & risk summary

General cautions

  • Pregnancy or breastfeeding

    Absolute

    No human reproductive safety data exists for this peptide. Effects on fetal development are unknown.

  • Children under 18

    Absolute

    No pediatric safety data. Not recommended for use in minors.

  • Known hypersensitivity

    Absolute

    Discontinue immediately if allergic reaction occurs (rash, swelling, difficulty breathing).

Risk summary(5)

Risks = level of concern: High · Moderate · Low · Theoretical

  • No human clinical safety data

    High
  • Unregulated product quality

    High
  • Unknown long-term effects

    Moderate
  • Theoretical epigenetic risks

    Theoretical
  • Contraindicated in pregnancy/breastfeeding

    Moderate
Safety & interactions in Full record

Further reading

Read Full record

This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer

Compiled from published research indexed through March 2026.